MiR-155 Activates Cytokine Gene Expression in Th17 Cells by Regulating the DNA-Binding Protein Jarid2 to Relieve Polycomb-Mediated Repression

Immunity

Volumn 40, Issue 6, 2014, Pages 865-879

  Escobar, Thelma M ^a   Kanellopoulou, Chrysi ^a   Kugler, David G ^a   Kilaru, Gokhul ^a   Nguyen, Cuong K ^a   Nagarajan, Vijayaraj ^a   Bhairavabhotla, Ravikiran K ^a   Northrup, Daniel ^b   Zahr, Rami ^a   Burr, Patrick ^a   Liu, Xiuhuai ^a   Zhao, Keji ^b   Sher, Alan ^a   Jankovic, Dragana ^a   Zhu, Jinfang ^a   Muljo, Stefan A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 22; JARID2 PROTEIN; MICRORNA 155; POLYCOMB REPRESSIVE COMPLEX 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; ENZYME REPRESSION; EPIGENETIC REPRESSION; HISTONE METHYLATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TOXOPLASMOSIS; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATIN; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN BINDING; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84902682101     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.03.014     Document Type: Article

References (59)

1. Abdel-Wahab O., Adli M., LaFave L.M., Gao J., Hricik T., Shih A.H., Pandey S., Patel J.P., Chung Y.R., Koche R., et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell 2012, 22:180-193.
2. Ben-Sasson S.Z., Hu-Li J., Quiel J., Cauchetaux S., Ratner M., Shapira I., Dinarello C.A., Paul W.E. IL-1 acts directly on CD4 Tcells to enhance their antigen-driven expansion and differentiation. Proc. Natl. Acad. Sci. USA 2009, 106:7119-7124.
3. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelly T.E., Saulsbury F.T., Chance P.F., Ochs H.D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001, 27:20-21.
4. Blüml S., Bonelli M., Niederreiter B., Puchner A., Mayr G., Hayer S., Koenders M.I., van den Berg W.B., Smolen J., Redlich K. Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum. 2011, 63:1281-1288.
5. Bolisetty M.T., Dy G., Tam W., Beemon K.L. Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. J.Virol. 2009, 83:12009-12017.
6. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27:68-73.
7. Bulger M., Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell 2011, 144:327-339.
8. Chung Y., Chang S.H., Martinez G.J., Yang X.O., Nurieva R., Kang H.S., Ma L., Watowich S.S., Jetten A.M., Tian Q., Dong C. Criticalregulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009, 30:576-587.
9. Ciofani M., Madar A., Galan C., Sellars M., Mace K., Pauli F., Agarwal A., Huang W., Parkurst C.N., Muratet M., et al. A validated regulatory network for Th17 cell specification. Cell 2012, 151:289-303.
10. Cobb B.S., Hertweck A., Smith J., O'Connor E., Graf D., Cook T., Smale S.T., Sakaguchi S., Livesey F.J., Fisher A.G., Merkenschlager M. A role for Dicer in immune regulation. J.Exp. Med. 2006, 203:2519-2527.
11. Dudakov J.A., Hanash A.M., Jenq R.R., Young L.F., Ghosh A., Singer N.V., West M.L., Smith O.M., Holland A.M., Tsai J.J., et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science 2012, 336:91-95.
12. Escobar T., Yu C.R., Muljo S.A., Egwuagu C.E. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 2013, 54:4017-4025.
13. Goswami R., Kaplan M.H. A brief history of IL-9. J.Immunol. 2011, 186:3283-3288.
14. Guo L., Wei G., Zhu J., Liao W., Leonard W.J., Zhao K., Paul W. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc. Natl. Acad. Sci. USA 2009, 106:13463-13468.
15. Hartman M.G., Lu D., Kim M.L., Kociba G.J., Shukri T., Buteau J., Wang X., Frankel W.L., Guttridge D., Prentki M., et al. Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol. Cell. Biol. 2004, 24:5721-5732.
16. Kanno Y., Vahedi G., Hirahara K., Singleton K., O'Shea J.J. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu. Rev. Immunol. 2012, 30:707-731.
17. Kim H., Kang K., Kim J. AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2. Nucleic Acids Res. 2009, 37:2940-2950.
18. Kohlhaas S., Garden O.A., Scudamore C., Turner M., Okkenhaug K., Vigorito E. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory Tcells. J.Immunol. 2009, 182:2578-2582.
19. Korn T., Bettelli E., Gao W., Awasthi A., Jäger A., Strom T.B., Oukka M., Kuchroo V.K. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
20. Krek A., Grün D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
21. Landeira D., Sauer S., Poot R., Dvorkina M., Mazzarella L., Jørgensen H.F., Pereira C.F., Leleu M., Piccolo F.M., Spivakov M., et al. Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators. Nat. Cell Biol. 2010, 12:618-624.
22. Lee P.P., Fitzpatrick D.R., Beard C., Jessup H.K., Lehar S., Makar K.W., Pérez-Melgosa M., Sweetser M.T., Schlissel M.S., Nguyen S., et al. A critical role for Dnmt1 and DNA methylation in Tcell development, function, and survival. Immunity 2001, 15:763-774.
23. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
24. Li G., Margueron R., Ku M., Chambon P., Bernstein B.E., Reinberg D. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev. 2010, 24:368-380.
25. Li X., Isono K., Yamada D., Endo T.A., Endoh M., Shinga J., Mizutani-Koseki Y., Otte A.P., Casanova M., Kitamura H., et al. Mammalian polycomb-like Pcl2/Mtf2 is a novel regulatory component of PRC2 that can differentially modulate polycomb activity both at the Hox gene cluster and at Cdkn2a genes. Mol. Cell. Biol. 2011, 31:351-364.
26. Liesenfeld O. Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease?. J.Infect. Dis. 2002, 185(Suppl 1):S96-S101.
27. Loeb G.B., Khan A.A., Canner D., Hiatt J.B., Shendure J., Darnell R.B., Leslie C.S., Rudensky A.Y. Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol. Cell 2012, 48:760-770.
28. Lu L.F., Thai T.H., Calado D.P., Chaudhry A., Kubo M., Tanaka K., Loeb G.B., Lee H., Yoshimura A., Rajewsky K., Rudensky A.Y. Foxp3-dependent microRNA155 confers competitive fitness to regulatory Tcells by targeting SOCS1 protein. Immunity 2009, 30:80-91.
29. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., Kanno Y., Spalding C., Elloumi H.Z., Paulson M.L., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
30. Muljo S.A., Ansel K.M., Kanellopoulou C., Livingston D.M., Rao A., Rajewsky K. Aberrant Tcell differentiation in the absence of Dicer. J.Exp. Med. 2005, 202:261-269.
31. Murugaiyan G., Beynon V., Mittal A., Joller N., Weiner H.L. Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. J.Immunol. 2011, 187:2213-2221.
32. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., Schluns K., Tian Q., Watowich S.S., Jetten A.M., Dong C. Essential autocrine regulation by IL-21 in the generation of inflammatory Tcells. Nature 2007, 448:480-483.
33. O'Connell R.M., Chaudhuri A.A., Rao D.S., Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA 2009, 106:7113-7118.
34. O'Connell R.M., Kahn D., Gibson W.S., Round J.L., Scholz R.L., Chaudhuri A.A., Kahn M.E., Rao D.S., Baltimore D. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory Tcell development. Immunity 2010, 33:607-619.
35. Oertli M., Engler D.B., Kohler E., Koch M., Meyer T.F., Müller A. MicroRNA-155 is essential for the Tcell-mediated control of Helicobacter pylori infection and for the induction of chronic gastritis and colitis. J.Immunol. 2011, 187:3578-3586.
36. Ouyang W., Rutz S., Crellin N.K., Valdez P.A., Hymowitz S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011, 29:71-109.
37. Pasini D., Cloos P.A., Walfridsson J., Olsson L., Bukowski J.P., Johansen J.V., Bak M., Tommerup N., Rappsilber J., Helin K. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 2010, 464:306-310.
38. Peng J.C., Valouev A., Swigut T., Zhang J., Zhao Y., Sidow A., Wysocka J. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 2009, 139:1290-1302.
39. Rhee H.S., Pugh B.F. ChIP-exo method for identifying genomic location of DNA-binding proteins with near-single-nucleotide accuracy. Curr. Protoc. Mol. Biol. 2012, 100:21.24.1-21.24.14.
40. Rodríguez C.I., Buchholz F., Galloway J., Sequerra R., Kasper J., Ayala R., Stewart A.F., Dymecki S.M. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 2000, 25:139-140.
41. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van Dongen S., Grocock R.J., Das P.P., Miska E.A., et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
42. Rutz S., Noubade R., Eidenschenk C., Ota N., Zeng W., Zheng Y., Hackney J., Ding J., Singh H., Ouyang W. Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in T(H)17 cells. Nat. Immunol. 2011, 12:1238-1245.
43. Shaw M.H., Kamada N., Kim Y.G., Núñez G. Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J.Exp. Med. 2012, 209:251-258.
44. Shen X., Kim W., Fujiwara Y., Simon M.D., Liu Y., Mysliwiec M.R., Yuan G.C., Lee Y., Orkin S.H. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 2009, 139:1303-1314.
45. Su I.H., Dobenecker M.W., Dickinson E., Oser M., Basavaraj A., Marqueron R., Viale A., Reinberg D., Wülfing C., Tarakhovsky A. Polycomb group protein ezh2 controls actin polymerization and cell signaling. Cell 2005, 121:425-436.
46. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J.L., et al. Regulation of the germinal center response by microRNA-155. Science 2007, 316:604-608.
47. Vahedi G., Takahashi H., Nakayamada S., Sun H.W., Sartorelli V., Kanno Y., O'Shea J.J. STATs shape the active enhancer landscape of Tcell populations. Cell 2012, 151:981-993.
48. van Dongen S., Abreu-Goodger C., Enright A.J. Detecting microRNA binding and siRNA off-target effects from expression data. Nat. Methods 2008, 5:1023-1025.
49. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing Tcells. Immunity 2006, 24:179-189.
50. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., Stockinger B. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
51. Wei G., Wei L., Zhu J., Zang C., Hu-Li J., Yao Z., Cui K., Kanno Y., Roh T.Y., Watford W.T., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ Tcells. Immunity 2009, 30:155-167.
52. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., Levy-Lahad E., Mazzella M., Goulet O., Perroni L., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001, 27:18-20.
53. Wilson M.S., Feng C.G., Barber D.L., Yarovinsky F., Cheever A.W., Sher A., Grigg M., Collins M., Fouser L., Wynn T.A. Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J.Immunol. 2010, 184:4378-4390.
54. Xu J., Yang Y., Qiu G., Lal G., Wu Z., Levy D.E., Ochando J.C., Bromberg J.S., Ding Y. c-Maf regulates IL-10 expression during Th17 polarization. J.Immunol. 2009, 182:6226-6236.
55. Yosef N., Shalek A.K., Gaublomme J.T., Jin H., Lee Y., Awasthi A., Wu C., Karwacz K., Xiao S., Jorgolli M., et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature 2013, 496:461-468.
56. Zenewicz L.A., Flavell R.A. Recent advances in IL-22 biology. Int. Immunol. 2011, 23:159-163.
57. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.
58. Zhu J., Paul W.E. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol. Rev. 2010, 238:247-262.
59. Zhu J., Yamane H., Paul W.E. Differentiation of effector CD4 Tcell populations. Annu. Rev. Immunol. 2010, 28:445-489.